Awakn Life Sciences Corp.

AWKNF · OTC
Analyze with AI
10/31/2024
7/31/2024
4/30/2024
1/31/2024
Operating Activities
Net Income-$376-$361-$545-$1,315
Dep. & Amort.$4$5$5$5
Deferred Tax$0$0$0$0
Stock-Based Comp.$27$33$37$94
Change in WC-$250-$93$2$698
Other Non-Cash$0$419$94-$118
Operating Cash Flow-$595$3-$501-$99
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0-$61
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$61
Investing Cash Flow$0$0$0$20
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$392$591$196$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$392$591$196-$33
Forex Effect-$4-$2$19-$15
Net Chg. in Cash-$207$592-$287-$147
Supplemental Information
Beg. Cash$713$121$407$555
End Cash$506$713$121$407
Free Cash Flow-$595$3-$501-$99